本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Sutro Biopharma Inc

1.09
+0.07006.86%
成交量:76.61万
成交额:84.87万
市值:9,240.39万
市盈率:-0.43
高:1.18
开:1.02
低:1.01
收:1.02
52周最高:4.80
52周最低:0.5231
股本:8,477.42万
流通股本:6,714.98万
量比:2.34
换手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-2.5119
每股收益(LYR):-2.9606
净资产收益率:-347.64%
总资产收益率:-27.54%
市净率:-2.88
市盈率(LYR):-0.37

数据加载中...

2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/06/25

重要事件披露

Form 8-K - Current report
2025/06/11

重要事件披露

Form 8-K - Current report
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/14

重要事件披露

Form 8-K - Current report
2025/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/13

重要事件披露

Form 8-K - Current report
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/10

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]